Ni Sa Bula Inc – Trademark Portfolio

Entity Type: 03

Ni Sa Bula Inc holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 2 Nice Classification classes. Currently, 6 trademarks are registered and 5 are pending. Notable registered marks include V, GUMM-EASE, KAVAGANDHA, MALO TONGA, and LOLOMA WAKA. The owner is based in Hayward, CA.

23785 Cabot Blvd

Suite 305

Hayward, CA 94545

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Ni Sa Bula Inc's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (10 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does Ni Sa Bula Inc have?

Ni Sa Bula Inc has 11 U.S. trademarks filed with the USPTO. Of these, 6 registered, 5 pending.

What trademark classes does Ni Sa Bula Inc file in?

Ni Sa Bula Inc files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Ni Sa Bula Inc's most well-known trademarks?

Ni Sa Bula Inc's registered trademark portfolio includes well-known marks such as V, GUMM-EASE, KAVAGANDHA, MALO TONGA, and LOLOMA WAKA. These are among 6 currently registered trademarks in the portfolio.

What is Ni Sa Bula Inc's trademark registration success rate?

Ni Sa Bula Inc has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 5 applications are pending review.